PublizoomCall for tenders Supplies
Accord-cadre ayant pour objet la fourniture de Palonosétron et d'Ondansétron
Notice published in French. The AI analysis summarises it for you in your language.
Tenders due closed — 7 October 2025 at 10:00
- Public buyer
- Centrale de Négociation pour les Achats Hospitaliers
Erpent - Place of performance
- 5101 Erpent
not published: buyer's address - Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 21 August 2025
- Notice language
- French
What is the authority looking for?
Supplies · Produits pharmaceutiques, vaccins
Accord-cadre ayant pour objet la fourniture de Palonosétron et d'Ondansétron
Where and when?
5101 Erpent (buyer's address)
Tenders due closed : 7 October 2025 at 10:00 Belgian time
Site visit and deadline for questions: stated in the specifications, not in the notice.
What budget?
Amount not published in the notice. The AI analysis and comparable tenders give an order of magnitude.
Why is this tender relevant to me?
Create your free account : we compare every tender with your trade and your area.
Can I consider bidding?
The AI analysis extracts the participation conditions, the contractor approval and the required documents. See the analysis and the verdict for your company
Nothing is assumed: what the notice does not say is marked "to check".
What do I need to do?
1. Read the analysis · 2. Check that you meet the conditions · 3. Prepare the response · 4. Submit on the official platform before the deadline.
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Accord-cadre ayant pour objet la fourniture de Palonosétron et d'Ondansétron
4 lots
- Lot 1 - Ondansétron solution injectable 4 mg/2ml
- Lot 2 - Ondansétron solution injectable 8 mg/4 ml
- Lot 3 - Ondansétron per os 8 mg
- Lot 4 - Palonosétron solution injectable 250 µg/5 ml
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- Fresenius Kabi · 3 contracts won
- Viatris · 3 contracts won
- Pfizer · 3 contracts won
- Becton Dickinson Benelux s.a. · 2 contracts won
- Roche Diagnostics Belgium SA · 1 contract won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Accord-cadre ayant pour objet la fourniture de produits de contraste iodés et d'agents de diagnostic par résonance magnétique Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025 |
GUERBET Bayer GE HEALTHCARE Bracco Imaging Europe |
€42,237,307 |
| Accord-cadre ayant pour objet la fourniture de Ceftriaxone Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025 |
Fresenius Kabi | €960,210 |
| Accord-cadre ayant pour objet la fourniture de Palonosétron et d'Ondansétron Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025 |
Viatris Grindeks Kalceks Belgium ACCORD HEALTHCARE |
€761,230 |
| Accord-cadre ayant pour objet la fourniture de Bosutinib Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025 |
Pfizer | €3,061,220 |
| Accord-cadre ayant pour objet la fourniture de Fingolimod 0,5 mg Centrale de Négociation pour les Achats Hospitaliers · 3 January 2025 |
Viatris | – |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 545087-2025.